Profile
Dipak Panigrahi served as the Chief Medical Officer and SVP-Research & Development at QLT, Inc. from 2010 to 2011.
He also worked as the Vice President-Medical Affairs at Sucampo Pharmaceuticals, Inc. Dr. Panigrahi received his undergraduate degree from The Johns Hopkins University and his graduate and doctorate degrees from Hahnemann University.
Former positions of Dipak Panigrahi
| Companies | Position | End |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 22/02/2011 |
| SUCAMPO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Dipak Panigrahi
| Hahnemann University | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
- Stock Market
- Insiders
- Dipak Panigrahi
